Neudle.com: multiple sclerosis clinically isolated syndrome

Differential
(Click to cross reference)

acute disseminated encephalomyelitis

addiction, heroin

addiction, heroin-neurologic complications with

adverse drug reaction

akinetic mute

algorithm

alternating rapid movement

amyloid angiopathy, cerebral

amyloid angiopathy, cerebral, inflammatory type

amyloid beta protein

amyloid beta-related angiitis

aneurysm

aneurysm, internal carotid artery

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiitis, isolated of CNS, benign focal

angiography, cerebral, beaded vessels

angiography, cerebral

angiography, cerebral, false negative

angiography, cerebral, reversible abnormality

antibodies to myelin basic protein

antimyelin antibodies

autoimmune cerebellar ataxia

Barkhof MR criteria for MS

basal ganglia, infarction

basal ganglia, lesion of

brain biopsy, false negative

brain volume

brainstem

brainstem, atrophy

brainstem, infarction of

brainstem, lesion of

bulbar palsy

calcium antagonist

Call-Fleming syndrome

carbamazepine

carbon monoxide poisoning

CAT scan, contrast enhanced, delayed

CAT scan, contrast enhanced, double dose

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, serial

central nervous system, infection of

central pontine myelinolysis

cerebellar ataxia, primary

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellum

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral edema

cerebral edema, vasogenic

cerebral infarction

cerebral infarction, hemorrhagic

cerebral infarction, small, deep

cerebral infarction, subcortical

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, culture of

cerebrospinal fluid, culture of, viral

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, protein of

cerebrospinal fluid, red cells in

cerebrovascular accident

cerebrovascular accident, bilateral

cerebrovascular accident, familial occurrence

cerebrovascular accident, multiple

cerebrovascular accident, recurrent

cerebrovascular accident, women

cervical spine

chasing the dragon

chemotherapy, CNS treatment and complications with

children

chin numbness

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

cognition

collagen vascular disease

coma

complications

confusion

confusional state, acute

controversies in neurology

cop 1

corpus callosum

corpus callosum, lesion of

degenerative diseases of CNS

dementia

dementia, rapidly progressive

dementia, screening for

demyelinating disease

dental procedure, neurologic complications with

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

dizziness

drug abuse

drug abuse, inhalation

drug abuse, neurologic complications of

drug induced neurologic disorders

electroencephalogram, abnormalities of

electromyogram

emotional lability

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, human immunodeficiency virus type 1

encephalitis, viral

encephalopathy

encephalopathy, Hashimoto's

encephalopathy, metabolic

endocarditis

epidemiology of neurology

Epstein-Barr virus

Erdheim-Chester disease

ethics in neurology

evoked potentials

extinction on double simultaneous stimulation

eye movement, disorders of

face, numbness of

facial weakness

facial weakness, bilateral

falling

familial

food-borne infection

fourth ventricle, shift of

gadolinium

gait disorder

gammaglobulin therapy, intravenous

gastroenteritis

gaze palsy

gaze palsy, horizontal

gender

gene mutation

genetic neurologic disorders

gliomatosis cerebri

glutamic acid decarboxylase, antibody

granular osmiphilic material

granulomatous disease

headache, sudden onset of

headache, thunderclap

hearing loss

hearing loss, sudden, unilateral

heel-knee-shin test

hemianopia, homonymous

hemianopia, isolated homonymous

hemiparesis

hepatolenticular degeneration(Wilson's disease)

heralding manifestation

herpes simplex virus

herpes virus

herpes zoster

herpes zoster, ophthalmicus

hiccoughs

histiocytosis

human immunodeficiency virus type 1

human immunodeficiency virus type 1, asymptomatic

hydrocephalus

hydrocephalus, exvacuo

hyperreflexia

hypersomnia

hypertensive encephalopathy

iatrogenic neurologic disorders

immunomodulation

immunosuppressive agents

incoordination

intellectual deficit

intellectual deterioration

internuclear ophthalmoplegia

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intravenous

Jakob-Creutzfeldt disease

Kayser-Fleischer ring

laughing, pathologic

leukoencephalopathy

leukoencephalopathy, differential diagnosis

leukoencephalopathy, toxic

level of consciousness, decreased

limbic encephalitis

listeria monocytogenes

lymphoma involving CNS

lymphoma, primary of CNS

MAGNIMS group

McDonald criteria for MS

medulla oblongata, lesion of

memory, impairment of

meningeal biopsy

meningeal enhancement

meningismus

meningitis, aseptic

mental nerve

mental nerve neuropathy

mental status, abnormal

migraine

mimics

misdiagnosis

mitochondrial disease

MRI, angiography, false negative

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, false negative

MRI, field strength

MRI, field strength, high

MRI, incidental finding

MRI, snowball lesions

multiple sclerosis, asymptomatic

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, clinically isolated syndrome

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, etiology of

multiple sclerosis, familial

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, MRI conversion

multiple sclerosis, MRI criteria

multiple sclerosis, pain in

multiple sclerosis, paroxysmal symptoms in

multiple sclerosis, pathogenesis

multiple sclerosis, preclinical

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

N-acetyl-L-aspartic acid

nausea and vomiting

neoplasm, metastatic

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic disease, diagnoses of

neurologic examination, focal

neurologic signs

neurologic symptoms

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuroophthalmology

neuropathology

neuroprotective agents

Notch3 gene

numb chin syndrome

nystagmus

nystagmus, primary position of gaze

ocular bobbing

optic nerve, lesion of

optic neuritis

optic neuritis, etiology of

optic neuritis, treatment of

optical coherence tomography

optokinetic nystagmus(O.K.N.)

optokinetic nystagmus, abnormal

osteoblastic lesions, causes of

pain

pain, back

paraneoplastic cerebellar degeneration

Parkinsonism syndrome

paroxysmal neurologic deficits

PAS positive

PAS positive material in the brain

periventricular leukomalacia

personality change

phenylketonuria

pleocytosis of cerebrospinal fluid

pons, infarction of

pons, lesion of

posterior fossa

posterior fossa, lesion of

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

primary lateral sclerosis

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

protein 14-3-3, cerebrospinal fluid

pseudobulbar palsy

psychiatric problems in neurologic disorders

pursuit eye movements, abnormal

pyramidal tract

pyramidal tract dysfunction

quadriparesis

quadriplegia

race

radiation therapy, CNS treatment and complications with

Rankin score

rapidly progressing neurologic illness

Red flags

rehabilitation for neurologic disorders

remote effect of cancer on the nervous system

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

review article

rheumatoid arthritis factor(R.A.factor)

rigidity

risk factors

saccadic eye movements, abnormal

scotoma, paracentral-homonymous

sedimentation rate, elevated

seizure

sensorineural hearing loss

serologic testing

sickle cell disease

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

spinal cord, cervical

spinal cord, ischemic lesion of

spinal cord, lesion of

standing difficulty

steroid

steroid therapy, CNS treatment and complications with

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

suicide

Susac's syndrome

symmetric brain lesions

symptomatic

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

tandem gait, ataxic

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

thyroiditis

tinnitus

tongue, impaired movements of

tonic spasms

toxic encephalopathy

treatment of neurologic disorder

tremor

trigeminal neuralgia

trigeminal neuropathy

trigeminal neuropathy, sensory

vasculitides

vasculopathy

vasoconstrictive drugs

vasospasm, cerebral

ventricular enlargement

visual evoked response

visual field defect

visual symptoms

walking, difficulty with

water channel antibodies

white matter disease, periventricular

work loss

workup

Showing articles 950 to 1000 of 4597 << Previous Next >>

An Open-Label Trial of Gabapentin Treatment of Paroxysmal Symptoms in Multiple Sclerosis Patients
Neurol 51:609-611, Solaro,C.,et al, 1998

Gabapentin Relieves Trigeminal Neuralgia in Multiple Sclerosis Patients
Neurol 51:611-614, Khan,O.A., 1998

Rate of Pregnancy-Related Relapse in Multiple Sclerosis
NEJM 339:285-291, 3391998., Confavreux,C.,et al, 1998

Spinal Cord Atrophy and Disability in MS
Neurol 51:234-238, Stevenson,V.L.,et al, 1998

Synergistic Immunomod Effects of Interferon-Beta1b & Phosphodiesterase Inhib Pentoxifylline in Pts with Relapsing-Remit MS
Ann Neurol 44:27-34, 71998., Weber,F.,et al, 1998

Effects of Copolymer-1 on Serial Gadolinium-Enhanced MRI in Relapsing Remitting Multiple Sclerosis
Neurol 50:1127-1133, Mancardi,G.L.,et al, 1998

Intravenous Immunoglobulin G Reduces MRI Activity in Relapsing Multiple Sclerosis
Neurol 50:1273-1281, Sorensen,P.S.,et al, 1998

Double-Blind, Randomized, Placebo-Controlled Study of Oral, High-Dose Methylprednisolone in Attacks of MS
Neurol 51:529-534, Sellebjerg,F.,et al, 1998

Randomized Trial Comparing Two Different High Doses of Methylprednisolone in MS, A Clinical and MRI Study
Neurol 50:1833-1836, Oliveri,R.L.,et al, 1998

Use of Corticosteroids in Multiple Sclerosis by Consultant Neurologists in the United Kingdom
JNNP 54:362-365, Tremlett,H.L.,et al, 1998

Current Immunotherapy in Multiple Sclerosis
Immunology and Cell Biology 76:55-64, Bashir,K.&Whitaker,J.N., 1998

Early Structural Changes in Acute MS Lesions Assessed by Serial magnetization Transfer Studies
Neurol 51:1150-1155, Dousset,V.,et al, 1998

Neuropsychiatric Sequelae One Year after a Minor Head Injury
JNNP 65:899-902,809, Deb,S.,et al, 1998

Diffusion Magnetic Resonance Imaging in Multiple Sclerosis
JNNP 64:S80-S84, Horsfield,M.A.,et al, 1998

Magnetic Resonance Imaging Features of Solitary Inflammatory Brain Masses
J Neuroimag 8:8-14, Bakshi,R.,et al, 1998

Trigeminal Neuralgia in Patients with Multiple Sclerosis:Lesion Localization with magnetic Resonance Imaging
Neurol 49:1142-1144, Gass,A.,et al, 1997

Myocardial Ischemia with Normal Coronary Arteries Associated with Thoracic Myelitis
NEJM 337:1920, Lalouschek,W.,et al, 1997

A Case-Control and Nerve Biopsy Study of CREST Mutliple Mononeuropathy
Neurol 49:1641-1645, Dyck,P.J.B.,et al, 1997

The Quality-of-Life Effects of Interferon Beta-1b in MS
Arch Neurol 54:1475-1480, Schwartz,C.E.,et al, 1997

Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997

Chromosome 19 Single-Locus & Multilocus Haplotype Assoc with MS, Evid of New Suscept Locus in Caucasian & Chinese Pts
JAMA 278:1256-1262, 12821997., Barcellos,L.F.,et al, 1997

Strong Clustering and Stereotyped Nature of Notch3 Mutations, in CADASIL Patients
Lancet 350:1511-1515, 14901997., Joutel,A.,et al, 1997

Multiple Sclerosis, Depression, and Suicide
BMJ 315:691-692, Feinstein,A., 1997

Clinicopath Conf
Oligodendroglioma, Mixed with Low-Grade Astrocytoma, Multiple Sclerosis, Case 12-1997, NEJM 336:1163, 11717., 1997

Concurrence of Multiple Sclerosis and Brain Tumor:Clinical Considerations
Neurol 48:1330-1333, Khan,O.A.,et al, 1997

Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997

Unusual Causes of Headache
Neurol 48:1494-1499, Ramadan,N.M., 1997

Epstein-Barr Virus Encephalomyelitis Diagnosed by Polymerase Chain Reaction:Detection of the Genome in the CSF
Neurol 48:1351-1355, Tselis,A.,et al, 1997

Lymphoproliferative Disorders and Motor Neuron Disease:An Update
Neurol 48:1671-1678, Gordon,P.H.,et al, 1997

Clinicopath Conf
Botulism, Case 22-1997, NEJM 337:184-190997., , 1997

Tizanidine for Spasticity
The Medical Letter 39:62, , 1997

Multiple Sclerosis Lesion Detection in the Brain:A Comparison of FLAIR & Conventional T2-Weighted Dual Spin Echo
Neurol 49:364-370, Gawne-Cain,M.L.,et al, 1997

Ischemic Lesion Volumes in Acute Stroke by Diffusion-Weighted MRI Correlate with Clinical Outcome
Ann Neurol 42:164-170, Lovblad,K-O.,et al, 1997

Clinical Characteristics of Patients with Motor Disability Due to Conversion Disorder:A Prospective Study
JNNP 63:83-88, Binzer,M.,et al, 1997

Cavernous Angioma of the Brain Stem Mimicking Multiple Sclerosis
NEJM 336:875-876, Vrethem,M.,et al, 1997

A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997

Offspring Recurrence Rates and Clinical Characteristics of Conjugal Multiple Sclerosis
Lancet 349:1587-1590, Robertson,N.P.,et al, 1997

Amelioration of Refractory Dysesthetic Limb Pain in Multiple Sclerosis by Gabapentin
Neurol 49:304-305, Samkoff,L.M.,et al, 1997

Doctors & Pts Don't Agree:Cross Sectional Study of Pts' & Doctors'Perceptions & Assessments of Disability in MS
BMJ 314:1580-1583, Rothwell,P.M.,et al, 1997

The Impact of Inpatient Rehabilitation on Progressive Multiple Sclerosis
Ann Neurol 42:236-244, Freeman,J.A.,et al, 1997

Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997

Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997

Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997

Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997

Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter 39:61-62, , 1997

Serum Angiotensin-Converting Enzyme in Multiple Sclerosis
Arch Neurol 54:1012-1015, Constantinescu,C.S.,et al, 1997

Hemiageusia:An Unusual Presentation of Multiple Sclerosis
JNNP 54:657, Pascual-Leone,A.,et al, 1997

Serial Neuropsychological Assess & Magnetic Resonance Imagingf Analysis in Multiple Sclerosis
Arch Neurol 54:1018-1025, Hohol,M.J.,et al, 1997

Randomised Trial of Oral and Intravenous Methylprednisolone in Acute Relapses of Multiple Sclerosis
Lancet 349:902-906, 8931997., Barnes,D.,et al, 1997

Frequency and Significance of Antinuclear Antibodies in Multiple Sclerosis
Neurol 49:857-861, Collard,R.C.,et al, 1997

Showing articles 950 to 1000 of 4597 << Previous Next >>